PBSV OTC
Pharma-Bio Serv, Inc.
1W: +13.6%
1M: -7.4%
3M: -12.3%
YTD: -4.5%
1Y: -25.4%
3Y: -40.2%
5Y: -12.6%
$0.50
+0.05 (+11.11%)
Weekly Expected Move ±24.4%
$0
$0
$0
$1
$1
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Income Trends
Revenue
$9M
-5.3% ▼
5Y CAGR: -16.0%
Gross Profit
$3M
+15.7% ▲
5Y CAGR: -15.3%
Operating Income
-$638K
+50.5% ▲
Net Income
-$100K
+87.1% ▲
EPS (Diluted)
$-0.00
+87.0% ▲
EBITDA
$135K
+112.2% ▲
5Y CAGR: -43.7%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $20M | $19M | $17M | $10M | $9M |
| YoY Growth | -6.7% | -3.6% | -12.5% | -44.0% | -5.3% |
| Cost of Revenue | $15M | $15M | $12M | $7M | $6M |
| Gross Profit | $5M | $5M | $5M | $3M | $3M |
| Gross Margin | 26.6% | 25.2% | 29.8% | 26.5% | 32.3% |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $9M | $4M | $4M | $4M | $4M |
| Operating Expenses | $9M | $4M | $4M | $4M | $4M |
| Operating Income | -$4M | $1M | $1M | -$1M | -$638K |
| Operating Margin | -19.2% | 6.1% | 6.6% | -13.5% | -7.1% |
| Interest Expense | $0 | $0 | $0 | $0 | $0 |
| Income Before Tax | -$2M | $1M | $2M | -$755K | -$94K |
| Tax Expense | $213K | $182K | $377K | $22K | $6K |
| Net Income | -$2M | $1M | $1M | -$778K | -$100K |
| Net Margin | -10.4% | 5.2% | 7.7% | -8.2% | -1.1% |
| EPS (Diluted) | $-0.09 | $0.04 | $0.06 | $-0.03 | $-0.00 |
| EBITDA | -$4M | $1M | $1M | -$1M | $135K |
| Shares Outstanding | 23M | 23M | 23M | 23M | 23M |